BBlogFlow

9 Things Experts Wish You’d Do in Midlife to Increase Longevity - The New York Times

·Jul 28, 2026
Source: The New York Times
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. The New York Times

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

New ‘Menopause at Work’ project aims to protect midlife women’s health and help them thrive at work - Harvard T.H. Chan School of Public Health

Joe Allen, professor of exposure assessment science, and Sasha Hamdani, psychiatrist and creator @thepsychdoctormd giving a virtual briefing about air quality and mental health. Thanks to a WIN Challenge grant, the Center for Health Communication will help online influencers share evidence-based information about menopause that can prompt employers to provide more support for women workers.

Harvard T.H. Chan School of Public Health·

Bioengineer.org | Viral blips during HIV therapy are common and rarely signal treatment failure, Swedish study finds - European AIDS Treatment Group

Bioengineer.org news storyFor people living with HIV, modern antiretroviral therapy can suppress the virus to levels below what standard laboratory tests can detect. Yet some patients on long-term treatment experience a curious phenomenon: a single test result showing a small, transient amount of virus in the blood, followed by an immediate return to undetectable levels. These events, known as viral blips, have puzzled clinicians and researchers for years, raising questions about whether they represent harmless statistical noise, brief bursts of viral production from hidden reservoirs, or early warnings of impending treatment failure. A new nationwide Swedish study, published in BMC Infectious Diseases, offers one of the most comprehensive answers to date. Drawing on the Swedish national InfCareHIV cohort, researchers analyzed data from 4,210 treatment-naïve adults who began antiretroviral therapy from 1 January 2007 onward, with follow-up data extracted through 30 September 2020. The median observation time was 5.5 years, with some individuals followed for as long as 13.7 years.

European AIDS Treatment Group·